Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs
- PMID: 18573784
- DOI: 10.1177/1066896907306084
Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs
Abstract
The expression of integrins alpha2beta1, alpha3beta1, and alpha5beta1 in 30 ameloblastomas (20 solid and 10 unicystic tumors), 12 adenomatoid odontogenic tumors (AOTs), and 5 human tooth germs in different stages of odontogenesis was analyzed. The distribution, location, pattern, and intensity of immunohistochemical expression were evaluated. Intensity was analyzed using scores (0 = absence, 1 = weak staining, and 2 = strong staining). No difference in the immunoexpression of the integrins was observed between solid and unicystic ameloblastomas. When these two ameloblastoma types were pooled into a single group, the following significant differences were found: immunoexpression of integrin alpha2beta1 was stronger in ameloblastomas than in AOTs and tooth germs, and the expression of integrin alpha5beta1 was stronger in ameloblastomas than in AOTs. The lack of detection of integrin alpha3beta1 in tooth germs and its detection in the odontogenic tumors studied suggest that this integrin might be used as a marker of neoplastic transformation in odontogenic tissues.
Similar articles
-
Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.Ann Diagn Pathol. 2007 Jun;11(3):199-205. doi: 10.1016/j.anndiagpath.2006.04.005. Ann Diagn Pathol. 2007. PMID: 17498594
-
Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):425-31. doi: 10.1016/j.tripleo.2009.10.032. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20219600
-
Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.J Oral Pathol Med. 2005 May;34(5):287-94. doi: 10.1111/j.1600-0714.2005.00311.x. J Oral Pathol Med. 2005. PMID: 15817072
-
Benign mixed odontogenic tumors.Semin Diagn Pathol. 1999 Nov;16(4):308-16. Semin Diagn Pathol. 1999. PMID: 10587274 Review.
-
Immunohistochemical biomarkers in ameloblastomas.Acta Odontol Scand. 2016 Nov;74(8):585-590. doi: 10.1080/00016357.2016.1224918. Epub 2016 Aug 30. Acta Odontol Scand. 2016. PMID: 27571891 Review.
Cited by
-
A case report and short review on changing trends in the site of occurrence of adenomatoid odontogenic tumor: Unravelling the past 15 years.Dent Res J (Isfahan). 2016 Sep;13(5):462-471. doi: 10.4103/1735-3327.192312. Dent Res J (Isfahan). 2016. PMID: 27857774 Free PMC article.
-
Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.Eur Arch Otorhinolaryngol. 2010 Feb;267(2):303-10. doi: 10.1007/s00405-009-0996-6. Epub 2009 May 23. Eur Arch Otorhinolaryngol. 2010. PMID: 19466441
-
Ameloblastic Carcinoma: A 40-Year Scoping Review of the Literature.Curr Issues Mol Biol. 2025 Apr 8;47(4):261. doi: 10.3390/cimb47040261. Curr Issues Mol Biol. 2025. PMID: 40699660 Free PMC article. Review.
-
Title of the article: diagnostic markers for odontogenic tumors: an insight: a review.Discov Oncol. 2024 Oct 15;15(1):558. doi: 10.1007/s12672-024-01237-0. Discov Oncol. 2024. PMID: 39404913 Free PMC article. Review.
-
FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor.Clin Oral Investig. 2021 Mar;25(3):1559-1567. doi: 10.1007/s00784-020-03465-4. Epub 2020 Jul 17. Clin Oral Investig. 2021. PMID: 32681423
MeSH terms
Substances
LinkOut - more resources
Full Text Sources